Immunologists at St. Jude Children’s Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., a member of the St. Jude Department of Immunology,…
Breast Cancer Mortality Rates Decline in Many Countries
Breast cancer mortality rates continue to decline in many nations, but a review of mortality trends in 47 countries around the world indicates some significant disparities, particularly in South Korea and some Latin American nations, according to results presented at the…
New Topical Immunotherapy Effective Against Early Skin Cancer
A combination of two topical drugs triggers a robust immune response against precancerous skin lesions, aiding in skin cancer prevention. The research, from the Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates…
Weight Loss May Help Prevent Multiple Myeloma
New research shows that excess weight increases the risk that a benign blood disorder will progress into multiple myeloma, a cancer of the blood. The study, by a team at Washington University School of Medicine in St. Louis, is published Nov….
Reason for Pancreatic Cancer’s Resistance to Chemotherapy Found
A University of Liverpool research team has published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy, focusing on Fibroblasts in pancreatic cancer. Pancreatic cancer is one of the leading causes…
Can We Put a Price on Healthcare Innovation in Cancer?
Most media attention is awarded to cancer’s success stories – new treatment breakthroughs are celebrated as researchers (and journalists) search for an exciting new “cure” for cancer. But what happens after these innovations hit the news? And who is going to…
Study Determines Efficacy of 2 Drugs to Treat a Form of Leukemia
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells, representing a significant advancement in T-Cell Leukemia Treatment. Although both drugs…
Tiny Gold Nanoparticles Could Help Develop New Pancreatic Cancer Therapy
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease, according…
Researchers Discover How Aspirin Fights Cancer
Get today’s drug discovery & development headlines and news – Sign up now! Taking aspirin reduces a person’s risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The Hormel Institute, affiliated with the…